NRXP
Price
$3.42
Change
-$0.08 (-2.29%)
Updated
Jun 27 closing price
Capitalization
66.7M
SNGX
Price
$1.36
Change
-$0.01 (-0.73%)
Updated
Jun 27 closing price
Capitalization
4.34M
Interact to see
Advertisement

NRXP vs SNGX

Header iconNRXP vs SNGX Comparison
Open Charts NRXP vs SNGXBanner chart's image
NRX Pharmaceuticals
Price$3.42
Change-$0.08 (-2.29%)
Volume$259.89K
Capitalization66.7M
Soligenix
Price$1.36
Change-$0.01 (-0.73%)
Volume$367.67K
Capitalization4.34M
NRXP vs SNGX Comparison Chart in %
Loading...
NRXP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NRXP vs. SNGX commentary
Jun 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NRXP is a Hold and SNGX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 29, 2025
Stock price -- (NRXP: $3.42 vs. SNGX: $1.36)
Brand notoriety: NRXP and SNGX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NRXP: 85% vs. SNGX: 477%
Market capitalization -- NRXP: $66.7M vs. SNGX: $4.34M
NRXP [@Biotechnology] is valued at $66.7M. SNGX’s [@Biotechnology] market capitalization is $4.34M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NRXP’s FA Score shows that 0 FA rating(s) are green whileSNGX’s FA Score has 1 green FA rating(s).

  • NRXP’s FA Score: 0 green, 5 red.
  • SNGX’s FA Score: 1 green, 4 red.
According to our system of comparison, NRXP is a better buy in the long-term than SNGX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NRXP’s TA Score shows that 2 TA indicator(s) are bullish while SNGX’s TA Score has 4 bullish TA indicator(s).

  • NRXP’s TA Score: 2 bullish, 6 bearish.
  • SNGX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, SNGX is a better buy in the short-term than NRXP.

Price Growth

NRXP (@Biotechnology) experienced а +4.91% price change this week, while SNGX (@Biotechnology) price change was -20.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NRXP($66.7M) has a higher market cap than SNGX($4.34M). NRXP YTD gains are higher at: 55.455 vs. SNGX (-49.536). SNGX has higher annual earnings (EBITDA): -10.78M vs. NRXP (-24.11M). SNGX has more cash in the bank: 7.3M vs. NRXP (5.55M). SNGX has less debt than NRXP: SNGX (79.1K) vs NRXP (8.4M). NRXP has higher revenues than SNGX: NRXP (0) vs SNGX (-117.03K).
NRXPSNGXNRXP / SNGX
Capitalization66.7M4.34M1,536%
EBITDA-24.11M-10.78M224%
Gain YTD55.455-49.536-112%
P/E Ratio0.36N/A-
Revenue0-117.03K-
Total Cash5.55M7.3M76%
Total Debt8.4M79.1K10,616%
FUNDAMENTALS RATINGS
NRXP vs SNGX: Fundamental Ratings
NRXP
SNGX
OUTLOOK RATING
1..100
2750
VALUATION
overvalued / fair valued / undervalued
1..100
57
Fair valued
22
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
3594
P/E GROWTH RATING
1..100
94100
SEASONALITY SCORE
1..100
n/a85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SNGX's Valuation (22) in the Biotechnology industry is somewhat better than the same rating for NRXP (57) in the null industry. This means that SNGX’s stock grew somewhat faster than NRXP’s over the last 12 months.

SNGX's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as NRXP (100) in the null industry. This means that SNGX’s stock grew similarly to NRXP’s over the last 12 months.

SNGX's SMR Rating (100) in the Biotechnology industry is in the same range as NRXP (100) in the null industry. This means that SNGX’s stock grew similarly to NRXP’s over the last 12 months.

NRXP's Price Growth Rating (35) in the null industry is somewhat better than the same rating for SNGX (94) in the Biotechnology industry. This means that NRXP’s stock grew somewhat faster than SNGX’s over the last 12 months.

NRXP's P/E Growth Rating (94) in the null industry is in the same range as SNGX (100) in the Biotechnology industry. This means that NRXP’s stock grew similarly to SNGX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NRXPSNGX
RSI
ODDS (%)
Bearish Trend 3 days ago
81%
Bullish Trend 3 days ago
82%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
70%
Bullish Trend 3 days ago
86%
Momentum
ODDS (%)
Bearish Trend 3 days ago
76%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
74%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 3 days ago
89%
Advances
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
76%
Declines
ODDS (%)
Bearish Trend 12 days ago
89%
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
86%
Bullish Trend 3 days ago
80%
Aroon
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
NRXP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IZM2.630.18
+7.35%
ICZOOM Group
HTHT34.23-0.05
-0.15%
H World Group Limited
GCBC22.93-0.20
-0.86%
Greene County Bancorp
ARRY6.44-0.06
-0.92%
Array Technologies
UCAR3.86-0.20
-4.90%
U Power Limited

NRXP and

Correlation & Price change

A.I.dvisor indicates that over the last year, NRXP has been closely correlated with CDTX. These tickers have moved in lockstep 85% of the time. This A.I.-generated data suggests there is a high statistical probability that if NRXP jumps, then CDTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRXP
1D Price
Change %
NRXP100%
-2.29%
CDTX - NRXP
85%
Closely correlated
+0.24%
NBY - NRXP
84%
Closely correlated
+0.97%
NCNA - NRXP
84%
Closely correlated
N/A
RNAC - NRXP
83%
Closely correlated
-6.81%
ALLR - NRXP
83%
Closely correlated
+2.12%
More

SNGX and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNGX has been closely correlated with ALLR. These tickers have moved in lockstep 85% of the time. This A.I.-generated data suggests there is a high statistical probability that if SNGX jumps, then ALLR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNGX
1D Price
Change %
SNGX100%
-0.73%
ALLR - SNGX
85%
Closely correlated
+2.12%
WINT - SNGX
82%
Closely correlated
+21.49%
RNAC - SNGX
81%
Closely correlated
-6.81%
NRXP - SNGX
81%
Closely correlated
-2.29%
CDTX - SNGX
81%
Closely correlated
+0.24%
More